Literature DB >> 1726645

Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.

K Iqbal1, I Grundke-Iqbal.   

Abstract

The most characteristic cellular change in Alzheimer's disease is the accumulation of aberrant filaments, the paired helical filaments (PHF), in the affected neurons. There is growing evidence from a number of laboratories that dementia correlates better with the accumulation of PHF than of the extracellular amyloid, the second major lesion of Alzheimer's disease. PHF are both morphologically and biochemically unlike any of the normal neurofibrils. The major polypeptides in isolated PHF are microtubule-associated protein tau. Tau in PHF is phosphorylated differently from tau in microtubules. This abnormal phosphorylation of tau in PHF occurs at several sites. The accumulation of abnormally phosphorylated tau in the affected neurons in Alzheimer's disease brain precedes both the formation and the ubiquitination of the neurofibrillary tangles. In Alzheimer's disease brain, tubulin is assembly competent, but the in vitro assembly of microtubules is not observed. In vitro, the phosphate groups in PHF are less accessible than those of tau to alkaline phosphatase. The in vitro dephosphorylated PHF polypeptides stimulate microtubule assembly from bovine tubulin. It is hypothesized that a defect in the protein phosphorylation/dephosphorylation system is one of the earliest events in the cytoskeletal pathology in Alzheimer's disease. Production of nonfunctional tau by its phosphorylation and its polymerization into PHF most probably contributes to a microtubule assembly defect, and consequently, to a compromise in both axoplasmic flow and neuronal function. Index Entries: Alzheimer's disease; mechanisms of neuronal degeneration; neurofibrillary changes; paired helical filaments: biochemistry; microtubule-associated protein tau; abnormal phosphorylation; ubiquitination; microtubule assembly; axoplasmic flow; protein phosphorylation/dephosphorylation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1726645     DOI: 10.1007/bf02935561

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  72 in total

1.  Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants.

Authors:  B H Anderton; D Breinburg; M J Downes; P J Green; B E Tomlinson; J Ulrich; J N Wood; J Kahn
Journal:  Nature       Date:  1982-07-01       Impact factor: 49.962

2.  About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation.

Authors:  M Barcikowska; H M Wisniewski; C Bancher; I Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition.

Authors:  K Iqbal; T Zaidi; C H Thompson; P A Merz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class.

Authors:  S H Yen; F Gaskin; S M Fu
Journal:  Am J Pathol       Date:  1983-12       Impact factor: 4.307

5.  Paired helical filaments associated with Alzheimer disease are readily soluble structures.

Authors:  R Rubenstein; R J Kascsak; P A Merz; H M Wisniewski; R I Carp; K Iqbal
Journal:  Brain Res       Date:  1986-04-30       Impact factor: 3.252

6.  Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease.

Authors:  S Bahmanyar; G A Higgins; D Goldgaber; D A Lewis; J H Morrison; M C Wilson; S K Shankar; D C Gajdusek
Journal:  Science       Date:  1987-07-03       Impact factor: 47.728

7.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

8.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

9.  Immunostaining of neurofibrillary tangles in Alzheimer's senile dementia with a neurofilament antiserum.

Authors:  D Dahl; D J Selkoe; R T Pero; A Bignami
Journal:  J Neurosci       Date:  1982-01       Impact factor: 6.167

10.  Tau protein function in living cells.

Authors:  D G Drubin; M W Kirschner
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  35 in total

1.  FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease.

Authors:  Waltraud Mair; Jan Muntel; Katharina Tepper; Shaojun Tang; Jacek Biernat; William W Seeley; Kenneth S Kosik; Eckhard Mandelkow; Hanno Steen; Judith A Steen
Journal:  Anal Chem       Date:  2016-03-07       Impact factor: 6.986

Review 2.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

3.  The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells.

Authors:  Cesar Augusto Dias de Paula; Fernando Enrique Santiago; Adriele Silva Alves de Oliveira; Fernando Augusto Oliveira; Maria Camila Almeida; Daniel Carneiro Carrettiero
Journal:  Cell Mol Neurobiol       Date:  2015-07-25       Impact factor: 5.046

4.  Epigallocatechin-3-gallate Alleviates Cognitive Deficits in APP/PS1 Mice.

Authors:  Jian Bao; Wei Liu; Hong-Yan Zhou; Yu-Ran Gui; You-Hua Yang; Meng-Juan Wu; Yi-Fan Xiao; Jin-Ting Shang; Gui-Feng Long; Xi-Ji Shu
Journal:  Curr Med Sci       Date:  2020-03-13

Review 5.  Brain-specific aminopeptidase: from enkephalinase to protector against neurodegeneration.

Authors:  Koon-Sea Hui
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

6.  Distribution of neuronal growth-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly.

Authors:  S S Zhan; W Kamphorst; W E Van Nostrand; P Eikelenboom
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

7.  Parkin attenuates wild-type tau modification in the presence of beta-amyloid and alpha-synuclein.

Authors:  Charbel E-H Moussa
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

8.  Proteomic analysis of protein phosphorylation and ubiquitination in Alzheimer's disease.

Authors:  Stefani N Thomas; Diane Cripps; Austin J Yang
Journal:  Methods Mol Biol       Date:  2009

9.  Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disease: relationship with the intellectual status in 29 cases.

Authors:  Y He; P Delaère; C Duyckaerts; M Wasowicz; F Piette; J J Hauw
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI.

Authors:  Anne Bertrand; Umer Khan; Dung M Hoang; Dmitry S Novikov; Pavan Krishnamurthy; Hameetha B Rajamohamed Sait; Benjamin W Little; Einar M Sigurdsson; Youssef Z Wadghiri
Journal:  Neuroimage       Date:  2012-08-31       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.